Yaroslavl State Technical University, Yaroslavl, Russian Federation.
Pharmaceutical Chemistry and Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa.
Drug Dev Res. 2019 Nov;80(7):970-980. doi: 10.1002/ddr.21576. Epub 2019 Jul 26.
In recent studies, we have investigated the monoamine oxidase (MAO) inhibition properties of pyrrolo[3,4-f]indole-5,7-dione and indole-5,6-dicarbonitrile derivatives. Since numerous high potency MAO inhibitors are present among these chemical classes, the present study synthesizes 44 additional derivatives in an attempt to further derive structure-activity relationships (SARs) and to establish optimal substitution patterns for MAO inhibition. The results show that, with the exception of one compound, all indole-5,6-dicarbonitrile derivatives (10) exhibit submicromolar IC values for the inhibition of MAO, with the most potent MAO-A inhibitor exhibiting an IC value of 0.006 μM while the most potent MAO-B inhibitor exhibits an IC value of 0.058 μM. Interestingly, an N-oxide derivative (4c) also proved to be a potent and nonspecific MAO inhibitor. With the exception of one compound, all of the pyrrolo[3,4-f]indole-5,7-diones (28) also exhibit submicromolar IC values for the inhibition of an MAO isoform. The most potent inhibitor exhibit an IC value of 0.011 μM for MAO-A. This study proposes that high potency MAO inhibitors such as those investigated here, may act as lead compounds for the development of treatments for neurodegenerative and neuropsychiatric disorders such as Parkinson's disease and depression.
在最近的研究中,我们研究了吡咯并[3,4-f]吲哚-5,7-二酮和吲哚-5,6-二腈衍生物的单胺氧化酶(MAO)抑制特性。由于这些化学类别中存在许多高活性 MAO 抑制剂,因此本研究合成了另外 44 种衍生物,试图进一步推导结构-活性关系(SAR),并确定 MAO 抑制的最佳取代模式。结果表明,除一种化合物外,所有吲哚-5,6-二腈衍生物(10)对 MAO 的抑制均表现出亚微摩尔的 IC 值,最有效的 MAO-A 抑制剂的 IC 值为 0.006 μM,而最有效的 MAO-B 抑制剂的 IC 值为 0.058 μM。有趣的是,一种 N-氧化物衍生物(4c)也被证明是一种有效的非特异性 MAO 抑制剂。除一种化合物外,所有吡咯并[3,4-f]吲哚-5,7-二酮(28)对 MAO 同工酶的抑制也表现出亚微摩尔的 IC 值。最有效的抑制剂对 MAO-A 的 IC 值为 0.011 μM。本研究提出,像这里研究的那样,高活性 MAO 抑制剂可能作为治疗神经退行性和神经精神疾病(如帕金森病和抑郁症)的先导化合物。